Submit an article

Acute lymphoblastic leukemia

Published on May 1, 2025
Application of Allo-HSCT in Children with Acute Lymphoblastic Leukemia
Published on May 1, 2025
Improving Survival Rates for Children with Acute Lymphoblastic Leukemia: A Single-Center Experience
Published on April 25, 2025
Induction Death and Treatment-related Mortality in First Remission of Children with Acute Lymphoblastic Leukemia
Published on April 25, 2025
Induction Complications and End-of-Induction MRD Outcomes in Acute Lymphoblastic Leukemia
Published on April 25, 2025
Acute Lymphoblastic Leukemia (ALL) Induction Related Mortality: A Quality Indicator in Paediatric Oncology Units
Published on April 25, 2025
A Pediatric Case of Relapsed Acute Lymphoblastic Leukemia (ALL): Severe Acute Graft-Versus-Host Disease (aGVHD) and Viral Infections Following Haploidentical Transplantation
Published on April 25, 2025
Treatment Outcomes for Childhood Acute Lymphoblastic Leukemia in Resource-limited Settings: A Hybrid Risk-stratified Treatment Protocol
Published on April 25, 2025
The Risk Factors and Outcomes of Neutropenic Colitis in Acute Lymphoblastic Leukemia During Chemotherapy
Published on April 25, 2025
Antifungal Prophylaxis During Induction Chemotherapy in Acute Lymphoblastic Leukemia: A Single Centre Experience
Published on April 25, 2025
Prognostic Evaluation of Protein Coding and Long Non-Coding RNAs in Pediatric T-Cell Acute Lymphoblastic Leukemia
Published on April 25, 2025
Outcome of Relapsed Childhood Acute Lymphoblastic Leukemia in Resource-poor Country: Warrants the Need for Immunotherapy
Published on April 1, 2025
B-cell precursor Acute Lymphoblastic Leukemia with high hyperdiploidy who have detectable residual disease at the end of induction can be salvaged by treatment escalation